[Characteristic metabolic effects of glucose, fructose, sorbitol, xylitol and their mixtures in intravenous long-term infusion].
D000090:Acetoacetates / Q000097:blood; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D004573:Electrolytes / Q000097:blood; D005632:Fructose / Q000378:metabolism / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D007773:Lactates / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D011773:Pyruvates / Q000097:blood; D013012:Sorbitol / Q000378:metabolism / Q000494:pharmacology*; D014527:Uric Acid / Q000378:metabolism; D014993:Xylitol / Q000378:metabolism / Q000494:pharmacology*
D000090:Acetoacetates; D004573:Electrolytes; D006885:Hydroxybutyrates; D007328:Insulin; D007773:Lactates; D008074:Lipoproteins; D011773:Pyruvates; D014527:Uric Acid; D005632:Fructose; D013012:Sorbitol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005947:Glucose; D001663:Bilirubin; D014993:Xylitol
Charakteristische Stoffwechselwirkungen von Glucose, Fructose, Sorbit, Xylit und deren Mischungen bei intravenöser Dauerinfusion